Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 62 points (0.4%) at 16,880 as of Tuesday, Oct. 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,323 issues advancing vs. 662 declining with 163 unchanged.

The Health Services industry currently sits up 0.8% versus the S&P 500, which is up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Stryker Corporation

(

SYK

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $1.16 (1.4%) to $85.54 on average volume. Thus far, 673,515 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $84.91-$85.81 after having opened the day at $85.01 as compared to the previous trading day's close of $84.38.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $31.9 billion and is part of the health care sector. Shares are up 12.1% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Stryker Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Stryker Corporation

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Stryker Corporation Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Intuitive Surgical

(

ISRG

) is up $11.29 (2.4%) to $489.00 on light volume. Thus far, 123,134 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 332,100 shares. The stock has ranged in price between $478.57-$489.20 after having opened the day at $479.79 as compared to the previous trading day's close of $477.71.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $17.3 billion and is part of the health care sector. Shares are up 24.5% year-to-date as of the close of trading on Monday. Currently there are 11 analysts who rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates

TheStreet Recommends

Intuitive Surgical

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Intuitive Surgical Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

Express Scripts

(

ESRX

) is up $0.65 (0.9%) to $73.93 on light volume. Thus far, 1.4 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $73.14-$73.96 after having opened the day at $73.57 as compared to the previous trading day's close of $73.28.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $54.9 billion and is part of the health care sector. Shares are up 4.8% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Express Scripts Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null